Theresa Willem

Theresa Willem

Auto-generated profile, based on publicly available information

Theresa Willem

Technical University of Munich

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2023 in Big Data & Society
Verified
Journal Article
Open access
RMRainer Mühlhoff
Rainer Mühlhoff
TWTheresa Willem
Theresa Willem
Social media advertising has revolutionised the advertising world by providing data-driven targeting methods. One area where social media advertising is just gaining a foothold is in the recruitment of clinical study participants. Here, as everywhere, social media advertising promises more yield per money spent because the technology can better reach highly specialised groups. In this article, we point out severe societal risks posed by advertising for clinical studies on social media. We show that social media advertising for clinical studies in many cases violates the privacy of individual users (R1), creates collective privacy risks by helping platform companies train predictive models of medical information that can be applied to all their users (R2), exploits the weaknesses of existing guidelines in (biomedical) research ethics (R3) and is detrimental to the quality of (biomedical) research (R4). We argue that the well-intentioned promises, which are often associated with the use of social media advertising for clinical studies, are untenable from a balanced point of view. Consequently, we call for updates of research ethics guidelines and better regulation of Big Data and inferential analytics. We conclude that social media advertising – especially with vulnerable patient populations – is not suitable as a recruitment tool for clinical studies as long as the processing of (even anonymised) social media usage data and the training of predictive models by data analytics and artificial intelligence companies is not sufficiently regulated.

3 May 2022 in Journal of Medical Internet Research
Verified
Journal Article
Open access
BZBettina Zimmermann
Bettina Zimmermann
TWTheresa Willem
Theresa Willem
CBCarl Justus Bredthauer
Carl Justus Bredthauer
ABAlena Buyx
Alena Buyx
Background: Social media recruitment for clinical studies holds the promise of being a cost-effective way of attracting traditionally marginalized populations and promoting patient engagement with researchers and a particular study. However, using social media for recruiting clinical study participants also poses a range of ethical issues. Objective: This study aims to provide a comprehensive overview of the ethical benefits and risks to be considered for social media recruitment in clinical studies and develop practical recommendations on how to implement these considerations. Methods: On the basis of established principles of clinical ethics and research ethics, we reviewed the conceptual and empirical literature for ethical benefits and challenges related to social media recruitment. From these, we derived a conceptual framework to evaluate the eligibility of social media use for recruitment for a specific clinical study. Results: We identified three eligibility criteria for social media recruitment for clinical studies: information and consent, risks for target groups, and recruitment effectiveness. These criteria can be used to evaluate the implementation of a social media recruitment strategy at its planning stage. We have discussed the practical implications of these criteria for researchers. Conclusions: The ethical challenges related to social media recruitment are context sensitive. Therefore, social media recruitment should be planned rigorously, taking into account the target group, the appropriateness of social media as a recruitment channel, and the resources available to execute the strategy.

24 December 2024 in Science and Engineering Ethics
Verified
Journal Article
Open access
PDF file
TWTheresa Willem
Theresa Willem
MFMarie-Christine Fritzsche
Marie-Christine Fritzsche
BZBettina M. Zimmermann
Bettina M. Zimmermann
ASAnna Sierawska
Anna Sierawska
SBSvenja Breuer
Svenja Breuer
ABAlena Buyx
Alena Buyx
Integrating artificial intelligence (AI) into critical domains such as healthcare holds immense promise. Nevertheless, significant challenges must be addressed to avoid harm, promote the well-being of individuals and societies, and ensure ethically sound and socially just technology development. Innovative approaches like Embedded Ethics, which refers to integrating ethics and social science into technology development based on interdisciplinary collaboration, are emerging to address issues of bias, transparency, misrepresentation, and more. This paper aims to develop this approach further to enable future projects to effectively deploy it. Based on the practical experience of using ethics and social science methodology in interdisciplinary AI-related healthcare consortia, this paper presents several methods that have proven helpful for embedding ethical and social science analysis and inquiry. They include (1) stakeholder analyses, (2) literature reviews, (3) ethnographic approaches, (4) peer-to-peer interviews, (5) focus groups, (6) interviews with affected groups and external stakeholders, (7) bias analyses, (8) workshops, and (9) interdisciplinary results dissemination. We believe that applying Embedded Ethics offers a pathway to stimulate reflexivity, proactively anticipate social and ethical concerns, and foster interdisciplinary inquiry into such concerns at every stage of technology development. This approach can help shape responsible, inclusive, and ethically aware technology innovation in healthcare and beyond.

22 May 2023 in Journal of Medical Internet Research
Verified
Journal Article
Open access
NGNina Goldman
Nina Goldman
TWTheresa Willem
Theresa Willem
ABAlena Buyx
Alena Buyx
BZBettina Zimmermann
Bettina Zimmermann
Background: The increasing use of social media opens new opportunities for recruiting patients for research studies. However, systematic evaluations indicate that the success of social media recruitment in terms of cost-effectiveness and representativeness depends on the type of study and its purpose. Objective: This study aims to explore the practical benefits and challenges of recruiting study participants with social media in the context of clinical and nonclinical studies and provide a summary of expert advice on how to conduct social media–based recruitment. Methods: We conducted semistructured interviews with 6 patients with hepatitis B who use social media and 30 experts from the following disciplines: (1) social media researchers or social scientists, (2) practical experts for social media recruitment, (3) legal experts, (4) ethics committee members, and (5) clinical researchers. The interview transcripts were analyzed using thematic analysis. Results: We found diverging expert opinions regarding the challenges and benefits of social media recruitment for research studies in four domains: (1) resources needed, (2) representativeness, (3) web-based community building, and (4) privacy considerations. Moreover, the interviewed experts provided practical advice on how to promote a research study via social media. Conclusions: Even though recruitment strategies should always be sensitive to individual study contexts, a multiplatform approach (recruiting via several different social media platforms) with mixed-methods recruitment (web-based and offline recruitment channels) is the most beneficial recruitment strategy for many research studies. The different recruitment methods complement each other and may contribute to improving the reach of the study, the recruitment accrual, and the representativeness of the sample. However, it is important to assess the context- and project-specific appropriateness and usefulness of social media recruitment before designing the recruitment strategy.

17 May 2022 in Journal of the European Academy of Dermatology and Venereology
Verified
Journal Article
Open access
TWT. Willem
T. Willem
SKSebastian Krammer
Sebastian Krammer
ABA.‐S. Böhm
A.‐S. Böhm
LFL.E. French
L.E. French
Daniela HartmannDaniela Hartmann
Daniela Hartmann
ABA. Buyx
A. Buyx
Background Visual data are particularly amenable for machine learning techniques. With clinical photography established for skin surveillance and documentation purposes as well as progress checks, dermatology is an ideal field for the development and application of emerging machine learning health care applications (ML-HCAs). To date, several ML-HCAs have detected malignant skin lesions on par with experts or found overlooked visual patterns that correlate with certain dermatological diseases. However, it is well established that ML-HCAs come with ethical and social implications. Objectives Currently, there is a lack of research that establishes model design, training, usage and regulation of such technologies sufficient to ensure ethically and socially responsible development and clinical translation, specifically within the field of dermatology. With this paper, we aim to give an overview of currently discussed ethical issues relating to dermatological ML-HCAs. Methods On the basis of a thematic, keyword-based literature search, we performed an ethical analysis against established frameworks of biomedical ethics. We combined our results with current, relevant normative machine learning ethics literature to identify the status quo of the ethics of ML-HCAs in dermatology. We describe the benefits and risks of dermatological ML-HCAs that are currently being developed for clinical purposes. Results The potential benefits range from better patient outcomes to better knowledge accessibility to decreasing health care disparities, that is, standards of care between different population groups. The risks associated with ML-HCAs range from confidentiality issues to individual patient outcomes as well as the exacerbation of prevalent health care disparities. We discuss the practical implications for all stages of dermatological ML-HCA development. Conclusion We found that ML-HCAs present stakeholder-specific risks for patients, health care professionals and society, which need to be considered separately. The discipline lacks sufficient biomedical ethics research that could standardize the approach to ML-HCA model design, training, use and regulation of such technologies.

13 October 2023 in Medical Physics
Verified
Journal Article
Open access
AWAlessandro Wollek
Alessandro Wollek
TWTheresa Willem
Theresa Willem
MIMichael Ingrisch
Michael Ingrisch
BSBastian Sabel
Bastian Sabel
TLTobias Lasser
Tobias Lasser
Background: Deep learning models are being applied to more and more use cases with astonishing success stories, but how do they perform in the real world? Models are typically tested on specific cleaned data sets, but when deployed in the real world, the model will encounter unexpected, out‐of‐distribution (OOD) data.Purpose: To investigate the impact of OOD radiographs on existing chest x‐ray classification models and to increase their robustness against OOD data.Methods: The study employed the commonly used chest x‐ray classification model, CheXnet, trained on the chest x‐ray 14 data set, and tested its robustness against OOD data using three public radiography data sets: IRMA, Bone Age, and MURA, and the ImageNet data set. To detect OOD data for multi‐label classification, we proposed in‐distribution voting (IDV). The OOD detection performance is measured across data sets using the area under the receiver operating characteristic curve (AUC) analysis and compared with Mahalanobis‐based OOD detection, MaxLogit, MaxEnergy, self‐supervised OOD detection (SS OOD), and CutMix.Results: Without additional OOD detection, the chest x‐ray classifier failed to discard any OOD images, with an AUC of 0.5. The proposed IDV approach trained on ID (chest x‐ray 14) and OOD data (IRMA and ImageNet) achieved, on average, 0.999 OOD AUC across the three data sets, surpassing all other OOD detection methods. Mahalanobis‐based OOD detection achieved an average OOD detection AUC of 0.982. IDV trained solely with a few thousand ImageNet images had an AUC 0.913, which was considerably higher than MaxLogit (0.726), MaxEnergy (0.724), SS OOD (0.476), and CutMix (0.376).Conclusions: The performance of all tested OOD detection methods did not translate well to radiography data sets, except Mahalanobis‐based OOD detection and the proposed IDV method. Consequently, training solely on ID data led to incorrect classification of OOD images as ID, resulting in increased false positive rates. IDV substantially improved the model's ID classification performance, even when trained with data that will not occur in the intended use case or test set (ImageNet), without additional inference overhead or performance decrease in the target classification. The corresponding code is available at https://gitlab.lrz.de/IP/a‐knee‐cannot‐have‐lung‐disease.